Glycosmedia

Diabetes News Service

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
  • News
  • Archive
  • Categories & Tags
  • Journal Watch
  • Updates
  • Education
  • Reviews
  • About us ▼
    • About Glycosmedia
    • Editorial Team
    • Frequently asked questions
    • Comments
    • Press Releases
    • Disclaimer
  • Subscribe
  • Contact

Diabetes News

Glycosmedia is dedicated to bringing free, non-promotional, editorially independent news to a global audience about developments in diabetes, and is primarily aimed at health professionals.


Clinical Utility of Cardiovascular Risk Scores for Identification of People With Type 2 Diabetes More Likely to Benefit From Either GLP-1 Receptor Agonist or SGLT2 Inhibitor Therapy

July 4th 2022

A greater increase in the rate of HHF relative to MACE was observed with progressively higher cardiovascular risk, regardless of the risk score applied. Consequently, SGLT2is may offer greater overall cardiovascular protection in those at highest MACE risk, not just those at highest HHF risk (Diabetes Care)

Categories: Cardiovascular, News
Tags: GLP-1 RA, SGLT2 inhibitors, Type 2 Diabetes

Categories: Cardiovascular
Tags: GLP-1 RA, SGLT2 inhibitors, Type 2 Diabetes

Association Between the Tissue and Circulating Advanced Glycation End-Products and the Micro- and Macrovascular Complications in Type 1 Diabetes: The DIABAGE Study

July 3rd 2022

Skin autofluorescence appears to be a useful marker for investigating both micro- and macrovascular complications in T1D. In this study, pentosidine was associated with macroangiopathy and MGH1 with nephropathy among the circulating AGEs. Furthermore, the correlations between PWV and AGEs may suggest their value in early prediction of vascular complications in T1D (Diabetes Therapy )

Categories: Nephropathy, News, Pathology
Tags: autofluorescence, Type 1 Diabetes

Categories: Nephropathy, Pathology
Tags: autofluorescence, Type 1 Diabetes

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

June 30th 2022

We estimate that CKD is present in one out of ten adults. These individuals experience significant adverse outcomes with associated costs. The prevalence of CKD is underestimated when using diagnostic codes alone. There is considerable public health potential in diagnosing CKD and providing treatments to those currently undiagnosed (The Lancet)

Categories: Nephropathy, News
Tags: chronic kidney disease

Categories: Nephropathy
Tags: chronic kidney disease

Prescribing costs of hypoglycaemic agents and associations with metabolic control in Wales; a national analysis of primary care data

June 30th 2022

Spend on hypoglycaemic agents is highly variable between practices and increased expenditure per patient is not associated with better glycemic control. Whilst newer, more expensive agents have additional benefits, in individuals where these advantages are more marginal widespread use of these agents have important cost implications (Diabetic Medicine)

Categories: Medication, News, Treatment
Tags: glycaemic control, primary care, Wales

Categories: Medication, Treatment
Tags: glycaemic control, primary care, Wales

Gut microbiota mediate melatonin signalling in association with type 2 diabetes

June 30th 2022

These findings uncover the importance of melatonin and melatonin-related bacteria and metabolites as potential therapeutic targets for type 2 diabetes (Diabetologia)

Categories: News, Pathology
Tags: melatonin, microbiota, Type 2 Diabetes

Categories: Pathology
Tags: melatonin, microbiota, Type 2 Diabetes

Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials

June 29th 2022

Dipeptidyl peptidase-4 inhibitors increased the risk of cholecystitis in randomised controlled trials, especially with a longer treatment duration, which requires more attention from physicians in clinical practice (BMJ)

Categories: Medication, News
Tags: biliary disease, DPP4 inhibitors, Type 2 Diabetes

Categories: Medication
Tags: biliary disease, DPP4 inhibitors, Type 2 Diabetes

Type 2 diabetes in adults: management

June 29th 2022

This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications (NICE)

Categories: Management, News, Treatment
Tags: Type 2 Diabetes

Categories: Management, Treatment
Tags: Type 2 Diabetes

Type 1 diabetes in adults: diagnosis and management

June 29th 2022

This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications (NICE)

Categories: Management, News
Tags: Type 1 Diabetes

Categories: Management
Tags: Type 1 Diabetes

Diabetes (type 1 and type 2) in children and young people: diagnosis and management

June 29th 2022

This guideline covers the diagnosis and management of type 1 and type 2 diabetes in children and young people aged under 18. The guideline recommends how to support children and young people and their families and carers to maintain tight control of blood glucose to reduce the long-term risks associated with diabetes (NICE)

Categories: Management, News, Paediatrics, Treatment
Tags: Type 1 Diabetes, Type 2 Diabetes

Categories: Management, Paediatrics, Treatment
Tags: Type 1 Diabetes, Type 2 Diabetes

Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease

June 29th 2022

Altogether, the results point to novel genes contributing to the pathogenesis of DKD (Diabetologia)

Categories: Genetics, Nephropathy, News
Tags: DKD, novel genes

Categories: Genetics, Nephropathy
Tags: DKD, novel genes

An Early Assessment of the Real-World Treatment Patterns of Type 2 Diabetes: A Comparison to the 2018 ADA/EASD Consensus Report Recommendations

June 29th 2022

Prevalence of guideline-aligned treatment use in 2019 was low, particularly since many patients fit into multiple risk groups with established treatment benefits (Diabetes Therapy)

Categories: News, Treatment
Tags: Type 2 Diabetes

Categories: Treatment
Tags: Type 2 Diabetes

Putative protective effects of sodium-glucose cotransporter 2 inhibitors on atrial fibrillation through risk factor modulation and off-target actions: potential mechanisms and future directions

June 29th 2022

This review discusses the SGLT2 and its role in glucose homeostasis, molecules inhibiting the transporter, possible physiological mechanisms responsible for the decreased incident atrial fibrillation in patients treated with SGLT2 inhibitors and proposes mechanistic studies to further our understanding of the biological processes involved (Cardiovascular Diabetology)

Categories: Cardiovascular, Medication, News
Tags: atrial fibrillation, SGLT2 inhibitors

Categories: Cardiovascular, Medication
Tags: atrial fibrillation, SGLT2 inhibitors

Clinical usefulness of quantifying microbial load from diabetic foot ulcers: a multicenter cohort study

June 28th 2022

Since patients with high microbial load had a worse outcome, quantitative cultures from DFUs can identify patients who would benefit from antibiotic therapy (Diabetes Research and Clinical Practice)

Categories: News, Wound Care
Tags: foot ulcer, microbial load

Categories: Wound Care
Tags: foot ulcer, microbial load

Psychosocial screening in a pediatric diabetes clinic: Adolescents’ and mothers’ perspectives

June 27th 2022

Study participants valued psychosocial screening and supported addressing mental health as a routine part of diabetes comprehensive care (Pediatric Diabetes)

Categories: News, Paediatrics, Psychological
Tags: psychosocial

Categories: Paediatrics, Psychological
Tags: psychosocial

Risky self-management behaviors in adolescents with type 1 diabetes: Measurement validation for the Diabetes-Specific Risk-Taking Inventory (DSRI)

June 27th 2022

Overall, initial psychometrics suggest the DSRI is a reliable and valid measure of risks that adolescents may take with their T1D care. This innovative self-report measure has potential to be an actionable clinical tool to screen for high-risk behaviors not routinely assessed in T1D clinical care (Pediatric Diabetes)

Categories: News, Paediatrics, Psychological
Tags: psychometrics, Type 1 Diabetes

Categories: Paediatrics, Psychological
Tags: psychometrics, Type 1 Diabetes

Long-Term Metabolic Outcomes after Gestational Diabetes Mellitus (GDM): Results from the Odense GDM Follow-Up Study (OGFUS)

June 25th 2022

Despite similar BMI, women with pGDM had a substantially higher risk of developing T2DM, prediabetes, and the MetS compared to controls. Both beta cell dysfunction and reduced insulin sensitivity seem to contribute to this increased risk (Journal of Diabetes Research)

Categories: Gestational, News
Tags: outcomes, Type 2 Diabetes

Categories: Gestational
Tags: outcomes, Type 2 Diabetes

Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study

June 24th 2022

Our results show an increased risk of mortality in those who did not receive all eight care processes in one or both of the previous two years. Our results provide evidence that the increased rate of non-COVID-19-related mortality in people with diabetes in England observed between July 3, and Oct 15 of 2021 is associated with a reduction in completion of routine diabetes care processes following the pandemic onset in 2020 (The Lancet Diabetes & Endocrinology)

Categories: News, Pathology
Tags: COVID-19, mortality

Categories: Pathology
Tags: COVID-19, mortality

A roadmap to achieve pharmacological precision medicine in diabetes

June 24th 2022

We propose a roadmap to achieve precision medicine as standard of care, to discuss current progress in relation to monogenic diabetes and type 2 diabetes, and to determine what additional work is required (Diabetologia)

Categories: Medication, News
Tags: Type 2 Diabetes

Categories: Medication
Tags: Type 2 Diabetes

Abnormalities of the oculomotor function in type 1 diabetes and diabetic neuropathy

June 23rd 2022

Abnormalities in oculomotor system function can be detected in patients with type 1 diabetes using a novel eye-tracking-based test. A larger cohort study may further determine thresholds of normality and validate whether eye-tracking can be used to non-invasively characterize early signs of diabetic neuropathy (Acta Diabetologica)

Categories: Monitoring, Neuropathy, News, Ophthalmology
Tags: oculomotor, Type 1 Diabetes

Categories: Monitoring, Neuropathy, Ophthalmology
Tags: oculomotor, Type 1 Diabetes

The role of mental disorders in precision medicine for diabetes: a narrative review

June 22nd 2022

Overall, this review demonstrates that addressing mental disorders as a facet of precision medicine could have considerable value for routine diabetes care and has the potential to improve diabetes outcomes (Diabetologia)

Categories: News, Psychological
Tags: mental disorders

Categories: Psychological
Tags: mental disorders
  • 1
  • 2
  • 3
  • …
  • 239
  • Next Page »

Subscribe

subscribe-iconFREE weekly updates by email Please CLICK HERE

Gold Sponsors

Boehringer IngelheimAstraZenecaNapp DiabetesNovo Nordisk

Silver Sponsors

About Ascensia Diabetes CareAbbott Diabetes CareWelsh Endocrinology and Diabetes Society (WEDS)

FUNDING NOTICE

The Glycosmedia website and newsletter has been made possible with funding support from our sponsors. None of our sponsors have control over the content of the website, newsletter, apps, Twitter feed or RSS newsfeed.

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com

Advertisers

CRC Press

The organisations advertising in this section do not have any input into, or editorial control over the content of this website.

News Archive

calendar-iconNews Archive ››

Categories

  • Audits
  • Bariatric
  • Biochemistry
  • Cardiovascular
  • Devices
  • Diagnosis
  • Diet
  • Education
  • Epidemiology
  • Genetics
  • Gestational
  • Guidance
  • Guidelines
  • Hepatology
  • Hypertension
  • Immunology
  • Management
  • Media
  • Medication
  • Meetings
  • Monitoring
  • Nephrology
  • Neuropathy
  • Nephropathy
  • Obesity
  • Ophthalmology
  • Paediatrics
  • Pathology
  • Pharma
  • Pharmacology
  • Physiology
  • Podiatry
  • Prediabetes
  • Prevalence
  • Prevention
  • Psychological
  • Reports
  • Research
  • Screening
  • Sponsorship
  • Technology
  • Testing
  • Transplantation
  • Treatment
  • Wound Care

To see all articles associated with a category just click on the category name.

Popular Tags

ADA BMI canagliflozin CGM CKD closed-loop COVID-19 dapagliflozin DPP4 DPP4 inhibitors Empagliflozin exenatide GLP-1 RA GLP1 glycaemic control HbA1c heart failure hyperglycemia hypoglycemia incretin insulin insulin pump Insulin resistance Ketoacidosis liraglutide metformin microvascular mortality NAFLD NICE pioglitazone retinopathy semaglutide SGLT2 inhibitors sitagliptin statin sulfonylureas Type 1 Diabetes Type 2 Diabetes Vitamin D

To see all articles associated with a tag just click on the tag name.

Complete list of Tags ››

Recent Book and Product Reviews

  • Roxburgh’s Common Skin Diseases 19th Edition
  • Oxford Handbook of Clinical Surgery 5th edition
  • Oxford Handbook of Medical Ethics and Law
  • Textbook of Emergency Cardiology

Recent Diabetes Updates

  • National Diabetes Audit.
  • Funding bids
  • Publication of Studies During 2016 – Type 2 Diabetes
  • “Attitudes to obesity” findings from the 2015 survey

Join us on Facebook

Join us on Facebook

Please share Glycosmedia:

Follow us on Twitter

My Tweets

mobileGlycosmedia is also available as an App:

For iPhone and iPad | For Android devices


Sponsorship and Advertising

For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com


Website by Wired up Wales

Copyright © 2022 Glycosmedia Partnership